Introduction
Gain new KOL insights on the latest events that have the potential to impact the treatment landscape of ulcerative colitis (UC). Topics covered include expert opinions on: Takeda announcing the presentation of real-world analyses for Entyvio (vedolizumab) in UC; InDex Pharmaceuticals announcing that it has enrolled the first patient in the Phase IIb CONDUCT trial for Kappaproct (cobitolimod); as well as Amgen announcing the European Commission approval of Amgevita (biosimilar adalimumab) in all available indications, including moderate-to-severe UC.
Business Questions:
How do KOLs regard real-world analyses of Entyvio?
What potential threats could Entyvio face in the future?
What are KOL views on Kappaproct and how would this agent be used if approved?
What impact is Amgevita/Amjevita expected to have on the UC anti-TNF market?
According to KOLs, which anti-TNF biosimilar is expected to have the most success in UC?
Table of Contents
for Ulcerative Colitis [2016]: Bulletin #3
Additional Details
Publisher
FirstWord Pharma
Publisher Information
Reference
107184 |
Report Format
Related Reports
| Title | Date Published | Price from | More Details |
|---|---|---|---|
| SAVE 15% today! Ulcerative Colitis - Pipeline Review, H1 2017 Ulcerative Colitis - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical an... | 09 May 2017 by Global Markets Direct | USD $1,700 (normally USD $2,000) |
More Info |
| SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2017 The Global Ulcerative Colitis Partnering Terms and Agreements since 2010 report provides understandi... | 01 Apr 2017 by Current Partnering | USD $1,271 (normally USD $1,495) |
More Info |
| SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2017 The Global Ulcerative Colitis Partnering Terms and Agreements since 2010 report provides understandi... | 01 Feb 2017 by Current Partnering | USD $1,271 (normally USD $1,495) |
More Info |
| SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016 The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce... | 01 Nov 2016 by Current Partnering | USD $1,271 (normally USD $1,495) |
More Info |
| SAVE 15% today! Global Ulcerative Colitis Partnering 2010-2016 The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce... | 01 Oct 2016 by Current Partnering | USD $1,271 (normally USD $1,495) |
More Info |
| SAVE 15% today! Ulcerative Colitis Global Clinical Trials Review, H2, 2016 Ulcerative Colitis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report,... | 28 Sep 2016 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
| SAVE 15% today! Ulcerative Colitis: KOL Insight Are UC biosimilars a real or perceived threat to branded drugs?Ulcerative colitis (UC) treatment is ... | 01 Sep 2016 by FirstWord Pharma | USD $6,715 (normally USD $7,900) |
More Info |
| SAVE 15% today! Ulcerative Colitis: Update Bulletin [Feb 2016] IntroductionGain new KOL insights on the latest events happening in Ulcerative Colitis. Topics cover... | 01 Feb 2016 by FirstWord Pharma | USD $846 (normally USD $995) |
More Info |
| SAVE 15% today! Ulcerative Colitis: KOL Insight Introductionipeline drugs are poised to reshape the way doctors treat ulcerative colitis (UC). But w... | 01 Dec 2015 by FirstWord Pharma | USD $6,715 (normally USD $7,900) |
More Info |
| SAVE 15% today! Ulcerative Colitis: KOL Insight IntroductionThe Ulcerative Colitis (UC) treatment market is already undergoing radical change as new... | 03 Dec 2014 by FirstWord Pharma | USD $6,715 (normally USD $7,900) |
More Info |
This report is published by FirstWord Pharma
Download Free Report Summary PDF
![Ulcerative Colitis [2016]: Bulletin #3 | Download PDF Summary](img/xpdf-summary.jpg.pagespeed.ic.PvEUQqtmCi.jpg "Ulcerative Colitis <br/>[2016]: Bulletin #3 | Download PDF Summary")
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Ordering Information
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types
Buy now using our secure payment system.